Prognosis and determinants of mortality of infective endocarditis in liver cirrhosis: a multicentre case-matched control study
Open Forum Infectious Diseases · 14.11.2026
DOI: 10.1093/ofid/ofag691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 14.11.2026. Verfasst von Marie Chauveau und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Infective endocarditis (IE) in patients with liver cirrhosis is poorly characterized, and the impact of cirrhosis severity on management and outcomes remains unclear. We aimed to describe the epidemiological, clinical, microbiological, therapeutic, and prognostic features of IE in patients with cirrhosis compared to controls without cirrhosis.
Methods
We conducted a retrospective bicentric cohort study including consecutive patients with definite or possible IE. Patients with cirrhosis were matched 1:4 with controls without cirrhosis on age, sex, center, comorbidities, prosthetic valve status, and causative microorganism. Cirrhosis severity was assessed using the Child–Pugh classification. Multivariable analyses were performed to identify factors associated with mortality.
Results
Among 1,550 screened IE episodes, 79 patients (5.1%) had cirrhosis and were matched to 316 controls. Baseline characteristics and IE predisposing conditions were similar between groups including microbiology. Cardiac surgery was performed less often in patients with cirrhosis than in controls (19/79 (24.1%) vs 146/316 (46.2%), p = 0.001). Cirrhosis-related complications were frequent and increased with disease severity, including acute kidney injury (p = 0.033). Ninety-day mortality was higher in patients with cirrhosis than in controls (28/79 [35.4%] vs 42/316 [13.3%], p < 0.001). In multivariable analysis, absence of cardiac surgery (aOR 2.2 ; 95%CI [1.0-4.9]), Child–Pugh B (aOR 2.9, 95% CI 1.1–7.5) and Child–Pugh C cirrhosis (aOR 6.9, 95% CI 2.3–20.6), but not Child–Pugh A (aOR 1.6, 95% CI 0.3–8.9), were independently associated with 90-day mortality.
Conclusion
IE prognosis in patients with cirrhosis is driven primarily by liver disease severity and associated organ dysfunction.
Zitieren
APA
Chauveau, M., Deschanvres, C., Camou, F., Ternacle, J., Corvec, S., Tourneau, T. L., Gaborit, B., Lecompte, A. S., Boutoille, D., Issa, N., & Lecomte, R. (2026). Prognosis and determinants of mortality of infective endocarditis in liver cirrhosis: a multicentre case-matched control study. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofag691
Vancouver
Chauveau M, Deschanvres C, Camou F, Ternacle J, Corvec S, Tourneau TL, et al. Prognosis and determinants of mortality of infective endocarditis in liver cirrhosis: a multicentre case-matched control study. Open Forum Infectious Diseases. 2026. doi:10.1093/ofid/ofag691
BibTeX
@article{Chauveau2026,
author = {Chauveau, Marie and Deschanvres, Colin and Camou, Fabrice and Ternacle, Julien and Corvec, Stéphane and Tourneau, Thierry Le and Gaborit, Benjamin and Lecompte, Anne Sophie and Boutoille, David and Issa, Nahéma and Lecomte, Raphaël},
title = {Prognosis and determinants of mortality of infective endocarditis in liver cirrhosis: a multicentre case-matched control study},
journal = {Open Forum Infectious Diseases},
year = {2026},
doi = {10.1093/ofid/ofag691}
}
EUVIMED